Vitiligo patients maintain re-pigmentation after ruxolitinib cream withdrawal

Presented By

Prof. John Harris, UMass Chan Medical School, MA, USA

Conference

AAD 2023

15 May, 2023 10:51

Enhancing re-pigmentation rates with topical ruxolitinib in all body areas

Presented By

Prof. Thierry Passeron, University Côte d’Azur, France

Trial

Phase 3, TRuE-V1; TRuE-V2

Conference

EADV 2022

5 November, 2022 10:50

Presented By

Dr David Rosmarin, Tufts Medical Center, USA

Trial

Phase 3, TRuE-V1; TRuE-V2

Conference

AAD 2022

17 May, 2022 11:05

Presented By

Dr Rachel Giles, Medicom

Conference

AAD 2022

14 April, 2022 11:02

Presented By

Dr David Rosmarin, Tufts Medical Center Boston, USA

Trial

Phase 3, TRuE-V1; TruE-V2

Conference

EADV 2021

18 November, 2021 13:27